Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 258 | 580 | 740 | 1,384 | 2,014 |
| Receivables | 130 | 109 | 72 | 95 | 116 |
| Inventories | 166 | 191 | 214 | 187 | 141 |
| Other current assets | 25 | 23 | 60 | 37 | 44 |
| TOTAL | $580 | $903 | $1,085 | $1,703 | $2,316 |
| Non-Current Assets | |||||
| PPE Net | 63 | 66 | 63 | 63 | 56 |
| Intangibles | 1,109 | 1,066 | 983 | 933 | 891 |
| TOTAL | $1,171 | $1,132 | $1,046 | $996 | $947 |
| Total Assets | $1,751 | $2,035 | $2,131 | $2,700 | $3,263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 915 | 492 | 480 | N/A | N/A |
| Accounts payable and accrued liabilities | 246 | 257 | 136 | 102 | 86 |
| TOTAL | $1,309 | $888 | $784 | $258 | $222 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 468 | 458 |
| TOTAL | $0 | $0 | $0 | $468 | $458 |
| Total Liabilities | $1,309 | $888 | $784 | $726 | $680 |
| Shareholders' Equity | |||||
| Retained earnings | -18,295 | -17,505 | -17,267 | -16,767 | -16,151 |
| Other shareholders' equity | 28 | 55 | 78 | 78 | 78 |
| TOTAL | $442 | $1,147 | $1,347 | $1,974 | $2,583 |
| Total Liabilities And Equity | $1,751 | $2,035 | $2,131 | $2,700 | $3,263 |